Our team comprises scientists, professors, and founders from Cornell and Stanford University, with expertise in metabolomics and computational biology. We have authored over 1,200 publications in leading journals, received over 350,000 citations, and designed top consumer healthcare products.

Daniel Gomari, PhD
Founder and CEO

Previously a Stanford University postdoctoral research fellow at Michael Snyder’s lab, where he led projects related to healthy aging and longevity extension. He did his PhD in Computational Biology, ​​where he built and applied novel network-based machine learning methods for computational drug repurposing, with applications in cancer and diabetes patient metabolomics data. Learn more

Prof. Michael Snyder, PhD
Scientific Co-founder

Currently the Stanford B. Ascherman Professor and Chair of Genetics and Director of Genomics and Personalized Medicine at Stanford University School of Medicine. He has authored 500+ publications in the field of precision medicine and has 4 previous biotech/healthtech  exits.
Learn more

Prof. Jan Krumsiek, PhD
Scientific Co-founder

Currently a Cornell University professor in computational biomedicine and metabolomics, he is a leading expert in building and applying AI tools for metabolomics data analysis and interpretation. He has authored 90+ publications in the field with a focus on chronic diseases, such as cancer, type 2 diabetes, and Alzheimer’s disease. Learn more

Prof. David Wishart, PhD
Scientific Advisor

Currently a Professor in the Departments of Biological Sciences and Computing Science at the University of Alberta. He founded and leads the Human Metabolome Project (HMP), a multi-university, multi-investigator project that catalogued 250,000+ human metabolites. He has authored 500+ publications with 100,000+ citations in the metabolomics field.
Learn more